Trademark: 97533023
Word

Status
Pending
Status Code
686
Status Date
Tuesday, February 20, 2024
Serial Number
97533023
Mark Type
2000
Filing Date
Wednesday, August 3, 2022
Published for Opposition
Tuesday, February 20, 2024

Trademark Owner History
Insilico Medicine IP Limited - Owner At Publication

Classifications
9 Downloadable mobile applications using artificial intelligence for automated machine learning in the field of drug design and development; recorded computer software platforms using artificial intelligence for automated machine learning in the field of drug design and development; recorded computer software using artificial intelligence for automated machine learning in the field of drug design and development; downloadable computer programs using artificial intelligence for automated machine learning in the field of drug design and development; recorded computer programs using artificial intelligence for automated machine learning in the field of drug design and development; computer operating programs, recorded; data processing apparatus being data processors; Electronic card readers; data processing equipment, namely, scanners; Downloadable computer software using artificial intelligence for machine learning in the field of drug design and development; Downloadable data sets using artificial intelligence for automated machine learning in the field of drug design and development; Data sets using artificial intelligence for automated machine learning in the field of drug design and development recorded on computer media; all of the above in relation to biotechnology, pharmaceutical research and development, drug discovery and development, clinical trials and analysis
5 Pharmaceutical preparations for the treatment of fibrosis, oncology, immunology, anti-infectious, central nervous system related and other diseases and disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Biological preparations for the treatment of cancer for medical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for treating fibrosis, oncology, immunology, anti-infectious, central nervous system related and other diseases and disorders; diagnostic preparations for medical purposes; dietary supplements for human beings; Dietetic foods and beverages adapted for medical use; adjuvants for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Medicinal preparations for the mouth to be applied in the form of capsules; Pharmaceutical and biological preparations for the treatment of fibrosis, oncology, immunology, anti-infectious, central nervous system related and other diseases and disorders and cancer for medical purposes
35 Compilation of information into computer databases; compilation of statistics; computerized database management of medical data and files; office functions in the nature of searching for data in computer files for others; data processing services; wholesale distributorships featuring for medical supplies; retail store services featuring medical supplies; retail and wholesale store services for pharmaceutical preparations; retail and wholesale stores services for medical diagnostic preparations; updating and maintenance of data in computer databases; retail and wholesale store services for medical supplies for diagnostic purposes; data search in computer files for others being office functions in the nature of searching for data in computer files for others
42 Provision of scientific research information; Drug discovery research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; product research and development in the field of biotechnology, molecular biology, pharmaceutics, oncology, immunology, biology and chemistry; Scientific and technological services, namely, scientific research and analysis in the field of pharmaceutical drugs and product research and design relating thereto; artificial intelligence driven robotics drug discovery scientific laboratory services; design and development of computer software; Software as a service (SAAS) services featuring software for use in database management in the field of drug design and development; software development in the framework of software publishing; updating of computer software; Platform as a service (PAAS) featuring computer software platforms for use in database management in the field of drug design and development; development of computer platforms; computer system design; rental of computer software for using artificial intelligence for automated machine learning in the field of drug design and development; creating and designing website-based indexes of information in the field of drug design and development for others using information technology services; computer programming; maintenance of computer software; research and development of new products for others; scientific and technological research relating to patent mapping; scientific research; platform as a service (PaaS) featuring computer software platforms for use in database management for using artificial intelligence for automated machine learning in the field of drug design and development; research in the field of artificial intelligence; conversion of data or documents from physical to electronic media; conversion of computer programs and data, other than physical conversion; electronic data storage; computer programming service for data processing; providing medical and scientific research information; Providing a web site that gives computer users the ability to upload and share video-based scientific protocols and other scientific-based videos; provision of scientific information in the fields of pharmaceutical research and development, drug discovery and medical and scientific research; all of the above in relation to biotechnology, pharmaceutical research and development, drug discovery and development, clinical trials and analysis
The mark consists of two diamond designs of which the smaller diamond is inside the larger diamond without overlapping. A triangular medical flask appears in the center of the mark surrounded by a processor chip on a circuit board within the smaller diamond. The lines of the circuit board constitute a four-fold symmetry.
Color is not claimed as a feature of the mark.

Trademark Events
Mar 4, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 20, 2024
Published For Opposition
Feb 1, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 1, 2024
Notification Of Notice Of Publication E-Mailed
Jan 16, 2024
Case Returned To Examination
Jan 16, 2024
Notice Of Allowance Cancelled
Dec 8, 2023
Jurisdiction Restored To Examining Attorney
Dec 8, 2023
Petition To Director - Change Basis - Granted
Dec 8, 2023
Petition To Director - Change Basis - Granted
Dec 7, 2023
Assigned To Petition Staff
Nov 13, 2023
Teas Petition To Amend Basis Received
Nov 9, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Nov 9, 2023
Teas Change Of Correspondence Received
Nov 9, 2023
Teas Change Of Domestic Representatives Address
Nov 9, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 9, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 9, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 9, 2023
Teas Change Of Owner Address Received
Oct 24, 2023
Noa E-Mailed - Sou Required From Applicant
Aug 29, 2023
Official Gazette Publication Confirmation E-Mailed
Aug 29, 2023
Published For Opposition
Aug 9, 2023
Notification Of Notice Of Publication E-Mailed
Jul 24, 2023
Approved For Pub - Principal Register
Jul 20, 2023
Examiner's Amendment Entered
Jul 20, 2023
Notification Of Examiners Amendment E-Mailed
Jul 20, 2023
Examiners Amendment E-Mailed
Jul 20, 2023
Examiners Amendment -Written
Jul 6, 2023
Previous Allowance Count Withdrawn
Jul 4, 2023
Withdrawn From Pub - Og Review Query
Jun 16, 2023
Approved For Pub - Principal Register
Jun 13, 2023
Examiner's Amendment Entered
Jun 13, 2023
Assigned To Lie
Jun 7, 2023
Notification Of Examiners Amendment E-Mailed
Jun 7, 2023
Examiners Amendment E-Mailed
Jun 7, 2023
Examiners Amendment -Written
May 20, 2023
Assigned To Examiner
Aug 25, 2022
Notice Of Design Search Code E-Mailed
Aug 24, 2022
New Application Office Supplied Data Entered
Aug 6, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24